Efficacy of Donepezil in Early-Stage Alzheimer Disease: A Randomized Placebo-Controlled Trial | December 2004

Articles

JAMA Neurology

https://jamanetwork.com/journals/jamaneurology/fullarticle/787258

Differential Effects of Acetylcholinesterase Inhibitors on Clinical Responses and Cerebral Blood Flow Changes in Patients with Alzheimer’s Disease: A 12-Month, Randomized, and Open-Label Trial | April 2015

Articles

Dementia and Geriatric Cognitive Disorders Extra

https://www.karger.com/Article/FullText/375527

Multicenter Randomized Clinical Trial of Donepezil for Memory Impairment in Multiple Sclerosis | April 2011

Articles

NCBI>Neurology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087469/

Withdrawal Syndrome After Donepezil Cessation in a Patient with Dementia | January 2012

Articles

Neurological Sciences

https://link.springer.com/article/10.1007%2Fs10072-012-0938-8

Attainment of Treatment Goals by People with Alzheimer’s Disease Receiving Galantamine: A Randomized Controlled Trial | March 2006

Articles

Canadian Medical Association Journal

http://www.cmaj.ca/content/174/8/1099.full

A Fixed-Dose Combination of Memantine Extended-Release and Donepezil in the Treatment of Moderate-to-Severe Alzheimer’s Disease | October 2016

Articles

Drug Design, Development and Therapy

https://www.dovepress.com/a-fixed-dose-combination-of-memantine-extended-release-and-donepezil-i-peer-reviewed-article-DDDT

Galantamine-Memantine Combination Superior to Donepezil-Memantine Combination in Alzheimer’s Disease: Critical Dissection with an Emphasis on Kynurenic Acid and Mismatch Negativity | February 2018

Articles (Manuscripts-Versions)

PubMed Central>Journal of Geriatric Care and Research

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457262/

Rivastigmine: The Advantages of Dual Inhibition of Acetylcholinesterase and Butyrylcholinesterase and Its Role in Subcortical Vascular Dementia and Parkinson’s Disease Dementia | April 2017

Articles

Clinical Interventions in Aging

https://www.dovepress.com/rivastigmine-the-advantages-of-dual-inhibition-of-acetylcholinesterase-peer-reviewed-article-CIA

Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial | July 2021

Abstracts

Journal of Neurotrauma

https://www.liebertpub.com/doi/10.1089/neu.2020.7146

Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study | February 2011

Articles

CNS Neuroscience and Therapeutics

https://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00244.x

Language Impairment in Alzheimer’s Disease and Benefits of Acetylcholinesterase Inhibitors | August 2013

Articles

Clinical Interventions in Aging

https://www.dovepress.com/language-impairment-in-alzheimer39s-disease-and-benefits-of-acetylchol-peer-reviewed-article-CIA

Galantamine Plasma Concentration and Cognitive Response in Alzheimer’s Disease | May 2019

Articles

PeerJ

https://peerj.com/articles/6887/

Effect of Donepezil for Dementia Prevention in Parkinson’s Disease with Severe Hyposmia (The DASH-PD Study): A Randomized Long-Term Placebo-Controlled Trial | July 2022

Articles

eClinicalMedicine

https://www.sciencedirect.com/science/article/pii/S2589537022003017

Effects of Donepezil on Cortical Activation in Mild Cognitive Impairment: A Pilot Double-Blind Placebo-Controlled Trial Using Functional MR Imaging | November 2008

Articles

American Journal of Neuroradiology

http://www.ajnr.org/content/30/2/411.full

A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients with Moderate to Severe Alzheimer Disease | October 2015

Articles

Journal of the American Medical Directors Association

https://www.sciencedirect.com/science/article/pii/S1525861015005587

Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil: A Randomized Controlled Trial | January 2004

Articles

Journal of the American Medical Association

https://jamanetwork.com/journals/jama/fullarticle/198033

Efficacy and Safety of Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch in Patients with Probable Alzheimer’s Disease | September 2011

Articles

Journal of Clinical Neurology

http://www.thejcn.com/DOIx.php?id=10.3988/jcn.2011.7.3.137

Rivastigmine from Capsules to Patch: Therapeutic Advances in the Management of Alzheimer’s Disease and Parkinson’s Disease Dementia | September 2014

Articles

Primary Care Companion for CNS Disorders

http://www.psychiatrist.com/pcc/article/Pages/2014/v16n05/14r01654.aspx

Donepezil+Chromone+Melatonin Hybrids as Promising Agents for Alzheimer’s Disease Therapy | February 2019

Articles

Journal of Enzyme Inhibition and Medicinal Chemistry

https://www.tandfonline.com/doi/full/10.1080/14756366.2018.1545766

Rivastigmine and Concomitant Memantine in Alzheimer’s Disease: Safety and Tolerability | September 2010

Abstracts

CNS Spectrums

https://doi.org/10.1017/S1092852900000572

Association Between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons with Alzheimer’s Disease | January 2020

Abstracts

Journal of the American Medical Directors Association

https://www.sciencedirect.com/science/article/abs/pii/S1525861019308412

Cardiac and Blood Pressure Safety of Transdermal Rivastigmine in Elderly Patients with Dementia with Lewy Bodies | October 2020

Abstracts

Alzheimer Disease and Associated Disorders

https://doi.org/10.1097/wad.0000000000000401

A Real-World Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-Diagnosed Alzheimer’s Disease Patients | May 2017

Articles

Neurology and Therapy

https://link.springer.com/article/10.1007/s40120-017-0067-7

The Effects of Donepezil on 15-Item Geriatric Depression Scale Structure in Patients with Alzheimer Disease | September 2016

Articles

Dementia and Geriatric Cognitive Disorders Extra

https://www.karger.com/Article/FullText/449244

Combination Therapy with Cilostazol, Aripiprazole, and Donepezil Protects Neuronal Cells from B-Amyloid Neurotoxicity through Synergistically Enhanced SIRT1 Expression | July 2020

Articles

Korean Journal of Physiology and Pharmacology

http://www.kjpp.net/journal/view.html?doi=10.4196/kjpp.2020.24.4.299

Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial | June 2020

Articles

International Journal of Preventive Medicine

http://www.ijpvmjournal.net/text.asp?2020/11/1/69/287176

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil | October 2022

Articles

Journal of Alzheimer’s Disease

https://www.doi.org/10.3233/JAD-220530

The Impact of Memantine in Combination with Acetylcholinesterase Inhibitors on Admission of Patients with Alzheimer’s Disease to Nursing Homes: Cost-Effectiveness Analysis in France | August 2013

Articles

European Journal of Health Economics

https://link.springer.com/article/10.1007/s10198-013-0523-y

Rivastigmine: An Open-Label, Observational Study of Safety and Effectiveness in Treating Patients with Alzheimer’s Disease for Up to 5 Years | January 2005

Articles

BMC Geriatrics

http://bmcgeriatr.biomedcentral.com/articles/10.1186/1471-2318-5-3

An Open Label Trial of Donepezil for Enhancement of Rapid Eye Movement Sleep in Young Children with Autism Spectrum Disorders | August 2011

Articles

NCBI>Journal of Child and Adolescent Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157749/

Memantine and Cholinesterase Inhibitor Combination Therapy for Alzheimer’s Disease: A Systematic Review | June 2012

Articles

BMJ Open

https://bmjopen.bmj.com/content/2/3/e000917.full

Dose and Plasma Concentration of Galantamine in Alzheimer’s Disease: Clinical Application | January 2013

Articles

Alzheimer’s Research and Therapy

http://alzres.biomedcentral.com/articles/10.1186/alzrt156

Adding Memantine to Rivastigmine Therapy in Patients with Mild-to-Moderate Alzheimer’s Disease: Results of a 12-Week, Open-Label Pilot Study | September 2006

Articles

NCBI>Primary Care Companion for CNS Disorders

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764534/

Memantine, Donepezil, or Combination Therapy: What Is the Best Therapy for Alzheimer’s Disease? A Network Meta‐Analysis | September 2020

Articles

Brain and Behavior

https://onlinelibrary.wiley.com/doi/full/10.1002/brb3.1831

Cognitive Efficacy (SIB) of 13.3 versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer’s Disease | September 2015

Articles

American Journal of Alzheimer’s Disease and Other Dementias

https://journals.sagepub.com/doi/full/10.1177/1533317515603687

Safety and Efficacy of Donepezil in African Americans with Mild-to-Moderate Alzheimer’s Disease | October 2006

Articles

NCBI>Journal of the National Medical Association

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569765/

A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer’s Disease | September 2015

Articles

Dementia and Geriatric Cognitive Disorders Extra

https://doi.org/10.1159/000439269

Effect of Donepezil on Hcy Level in Serum of Alzheimer’s Disease Patients and Correlation Analysis of Hcy and Dyssomnia | December 2018

Articles

Experimental and Therapeutic Medicine

https://www.spandidos-publications.com/10.3892/etm.2018.7071

Rivastigmine for Alzheimer’s Disease: Improvement versus Reduced Worsening | August 2000

Articles

NCBI>Primary Care Companion for CNS Disorders

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181126/

Concurrent Administration of Donepezil HCL and Risperidone in Patients with Schizophrenia: Assessment of Pharmacokinetic Changes and Safety Following Multiple Oral Doses | November 2004

Articles

NCBI>British Journal of Clinical Pharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884550/

Long-Term Effect of Galantamine on Cognitive Function in Patients with Alzheimer’s Disease versus a Simulated Disease Trajectory: An Observational Study in the Clinical Setting | April 2017

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/long-term-effect-of-galantamine-on-cognitive-function-in-patients-with-peer-reviewed-article-NDT

Weight Loss Associated with Cholinesterase Inhibitors in Patients with Dementia in a National Healthcare System | August 2015

Articles (Manuscripts-Versions)

PubMed Central>Journal of the American Geriatrics Society

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737921/

Memantine ER and Donepezil Treatment Maintains Cognitive Improvements versus Donepezil Monotherapy: Post Hoc Analyses from a Placebo-Controlled Study in Patients with Moderate-to-Severe Alzheimer’s Disease (Meetings-Events) | April 2018

Abstracts

Neurology

https://n.neurology.org/content/90/15_Supplement/P6.176

Cholinesterase Inhibitor Treatment Alters the Natural History of Alzheimer’s Disease | March 2002

Articles

Journal of Neurology, Neurosurgery and Psychiatry

https://jnnp.bmj.com/content/72/3/310.full

Community Pharmacists’ Knowledge Regarding Donepezil Averse Effects and Self-Care Recommendations for Insomnia for Persons with AD | July 2017

Articles

Pharmacy

https://www.mdpi.com/2226-4787/5/3/42

Donepezil Delays Progression to AD in MCI Subjects with Depressive Symptoms | June 2009

Articles

NCBI>Neurology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697965/

Hippocampal Atrophy But Not White-Matter Changes Predicts the Long-Term Cognitive Response to Cholinesterase Inhibitors in Alzheimer’s Disease | November 2015

Articles

Alzheimer’s Research and Therapy

http://alzres.biomedcentral.com/articles/10.1186/s13195-015-0155-9

Persistence of Cholinesterase Inhibitor Treatment in Dementia: Insights from a Naturalistic Study | March 2013

Articles

Dementia and Geriatric Cognitive Disorders Extra

https://www.karger.com/Article/FullText/345279

Degree of Inhibition of Cortical Acetylcholinesterase Activity and Cognitive Effects by Donepezil Treatment in Alzheimer’s Disease | March 2005

Articles

Journal of Neurology, Neurosurgery and Psychiatry

https://jnnp.bmj.com/content/76/3/315.full

Galantamine Compared to Risperidone in Neuropsychiatric and Behavioural Symptoms in Alzheimer Patients: A One-Center Clinical Trial in 100 Patients (Meetings-Events) | June 2010

Abstracts

European Psychiatry

https://www.sciencedirect.com/science/article/abs/pii/S0924933810715765